Zuyi Ma

1.2k total citations · 1 hit paper
41 papers, 766 citations indexed

About

Zuyi Ma is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Zuyi Ma has authored 41 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 15 papers in Surgery. Recurrent topics in Zuyi Ma's work include Pancreatic and Hepatic Oncology Research (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Ferroptosis and cancer prognosis (7 papers). Zuyi Ma is often cited by papers focused on Pancreatic and Hepatic Oncology Research (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Ferroptosis and cancer prognosis (7 papers). Zuyi Ma collaborates with scholars based in China, Germany and India. Zuyi Ma's co-authors include Chuanzhao Zhang, Shanzhou� Huang, Hongkai Zhuang, Zixuan Zhou, Baohua Hou, Kaijun Huang, Xiaoshun He, Shiye Ruan, Fei Ji and Zhenchong Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Cell Death and Differentiation.

In The Last Decade

Zuyi Ma

38 papers receiving 758 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation

2020 290 citations Chuanzhao Zhang, Shanzhou� Huang et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zuyi Ma China	14	465	295	262	146	121	41	766
Hongkai Zhuang China	14	553 1.2×	369 1.3×	279 1.1×	223 1.5×	143 1.2×	51	926
Alexandra Drakaki United States	12	430 0.9×	357 1.2×	215 0.8×	103 0.7×	65 0.5×	37	758
Kshitij S. Arora United States	13	284 0.6×	158 0.5×	254 1.0×	113 0.8×	149 1.2×	37	684
Fangchao Zheng China	9	272 0.6×	203 0.7×	425 1.6×	278 1.9×	79 0.7×	33	800
Tessa Y. S. Le Large Netherlands	15	226 0.5×	210 0.7×	407 1.6×	116 0.8×	122 1.0×	28	656
Lydia Meder Germany	13	395 0.8×	198 0.7×	408 1.6×	311 2.1×	121 1.0×	21	783
Yongkui Lu China	11	220 0.5×	145 0.5×	350 1.3×	259 1.8×	108 0.9×	20	657
Dat Nguyen United States	10	414 0.9×	237 0.8×	238 0.9×	71 0.5×	38 0.3×	20	701
Chuntao Wu China	16	193 0.4×	175 0.6×	431 1.6×	116 0.8×	138 1.1×	30	686
Chengli Du China	17	719 1.5×	509 1.7×	236 0.9×	143 1.0×	52 0.4×	32	1.0k

Countries citing papers authored by Zuyi Ma

Since Specialization

Citations

This map shows the geographic impact of Zuyi Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuyi Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuyi Ma more than expected).

Fields of papers citing papers by Zuyi Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuyi Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuyi Ma. The network helps show where Zuyi Ma may publish in the future.

Co-authorship network of co-authors of Zuyi Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Zuyi Ma. A scholar is included among the top collaborators of Zuyi Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuyi Ma. Zuyi Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Zuyi, Detao Zhang, Yanbing Wang, et al.. (2025). Multi-ancestry genome-wide association meta-analysis identifies novel associations and informs genetic risk prediction for Hirschsprung disease. EBioMedicine. 115. 105680–105680. 1 indexed citations

Chen, Yuqiong, Kai Song, Yi Zheng, et al.. (2025). Exosomes derived from M1-macrophage promote enteric neuronal injury via MMP8-TGF-β pathway. Journal of Advanced Research.

Ma, Zuyi, et al.. (2024). AMDHD1 acts as a tumor suppressor and contributes to activation of TGF-β signaling pathway in cholangiocarcinoma. Cell Death and Differentiation. 32(1). 162–176. 3 indexed citations

Ma, Zuyi, et al.. (2023). Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma. BMC Cancer. 23(1). 404–404. 4 indexed citations

Ma, Zuyi, et al.. (2023). Glucose-6-phosphate isomerase deficiency hemolysis. Quantitative Imaging in Medicine and Surgery. 13(12). 8869–8872. 1 indexed citations

Liu, Chunsheng, Zuyi Ma, Zhenchong Li, et al.. (2023). A hierarchical prognostic model for Co-diabetes pancreatic adenocarcinoma. Heliyon. 9(11). e21642–e21642. 1 indexed citations

Huang, Shanzhou�, Zuyi Ma, Qi Zhou, et al.. (2022). Genome-Wide CRISPR/Cas9 Library Screening Identified that DUSP4 Deficiency Induces Lenvatinib Resistance in Hepatocellular Carcinoma. International Journal of Biological Sciences. 18(11). 4357–4371. 45 indexed citations

Ma, Zuyi, Zhenchong Li, Shujie Wang, et al.. (2022). ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway. Journal of Experimental & Clinical Cancer Research. 41(1). 130–130. 23 indexed citations

Li, Zhenchong, Zuyi Ma, Qi Zhou, et al.. (2022). Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of pancreatic cancer. Heliyon. 8(11). e11321–e11321. 2 indexed citations

10.

Ma, Zuyi, Zhenchong Li, Shujie Wang, et al.. (2021). SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. Volume 8. 899–912. 16 indexed citations

11.

Zhuang, Hongkai, Shujie Wang, Bo Chen, et al.. (2021). Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas. Frontiers in Immunology. 12. 790661–790661. 15 indexed citations

12.

Zhou, Zixuan, Zuyi Ma, Zhenchong Li, et al.. (2021). CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer. Journal of Cancer. 12(19). 5797–5806. 13 indexed citations

13.

Chen, Mingyu, Jiasheng Cao, Yukai Xiang, et al.. (2021). Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study. Surgery. 169(6). 1304–1311. 13 indexed citations

14.

Ma, Zuyi, Zhenchong Li, Zixuan Zhou, et al.. (2021). Development of a KRAS‐Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer. BioMed Research International. 2021(1). 9949272–9949272. 6 indexed citations

15.

Zhuang, Hongkai, Shanzhou� Huang, Zixuan Zhou, et al.. (2020). A four prognosis-associated lncRNAs (PALnc) based risk score system reflects immune cell infiltration and predicts patient survival in pancreatic cancer. Cancer Cell International. 20(1). 493–493. 15 indexed citations

16.

Zhang, Chuanzhao, Shanzhou� Huang, Hongkai Zhuang, et al.. (2020). YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Oncogene. 39(23). 4507–4518. 290 indexed citations breakdown →

17.

Zou, Yiping, Shiye Ruan, Zhixiang Jian, et al.. (2020). Development of a Nomogram to Predict Disease-Specific Survival for Patients After Resection of a Non-Metastatic Adenocarcinoma of the Pancreatic Body and Tail. Frontiers in Oncology. 10. 526602–526602. 9 indexed citations

18.

Zhuang, Hongkai, Zixuan Zhou, Zuyi Ma, et al.. (2020). Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection. Frontiers in Oncology. 10. 556489–556489. 6 indexed citations

19.

Ma, Zuyi, Yuanfeng Gong, Hongkai Zhuang, et al.. (2020). Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management. World Journal of Gastroenterology. 26(19). 2305–2322. 98 indexed citations

20.

Hou, Baohua, Yuanfeng Gong, Fengying Dong, et al.. (2019). Selenium concentration, dietary intake and risk of hepatocellular carcinoma – A systematic review with meta-analysis. Nutrición Hospitalaria. 36(6). 1430–1437. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact